orbactiv
orbactiv: sourced relationships with 1 company · 1 clinical trial tracked.
orbactiv evidence translation
What we can confirm
1 tracked trial
What it means
What to watch
Prepared research question
How could orbactiv → MLNT affect its developer, and what evidence supports the link?
Traceable citations · Unknowns marked
See linked entities and source evidence1 indications · 0 study sponsors
Related indications
Study sponsors
No additional listed-company sponsor is linked.
Dated Pipeline Records (1)
| Company | Dated record stage |
|---|---|
| MELINTA THERAPEUTICS, INC. /NEW/ (MLNT) acute bacterial skin or skin structure infections (ABSSSI) | Approved |
Clinical Trial Registry Records (1)
A Multicenter, Open-Label, Evaluator-Blinded, Randomized Study to Evaluate the Safety and Tolerability of Single-Dose Intravenous Oritavancin for the Treatment of Pediatric Subjects With Acute Bacterial Skin and Skin Structure Infections
Primary endpoint: Number of Participants Experiencing Treatment-emergent Adverse Events (TEAEs)
Frequently asked questions
Which companies have sourced relationships with orbactiv?
orbactiv has dated SEC/FDA relationship records for MELINTA THERAPEUTICS, INC. /NEW/.
How many clinical trials involve orbactiv?
BioSniper tracks 1 clinical trial involving orbactiv.